Cargando…

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma

Elevated levels of apoB-100 containing lipoproteins and markers of systemic inflammation are often observed in patients with cardiovascular diseases. The concentrations can be reduced by pharmacotherapy or extracorporeal treatment. The sorbent, which removes CRP and atherogenic lipoproteins, simulta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dmitrieva, O. A., Ovchinnikova, E. D., Utkina, E. A., Levashov, P. A., Afanasieva, O. I., Adamova, I. Y., Pokrovsky, S. N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807530/ https://www.ncbi.nlm.nih.gov/pubmed/35127146 http://dx.doi.org/10.32607/actanaturae.11292

Ejemplares similares

Covalently immobilized chemically modified lysozyme as a sorbent for bacterial endotoxins (lipopolysaccharides)
por: Levashov, Pavel A., et al.
Publicado: (2019)

Pro-Atherogenic and Pro-Oxidant Diets Influence Semen and Blood Traits of Rabbit Bucks
por: Mattioli, Simona, et al.
Publicado: (2023)

Discovery of novel peptides targeting pro-atherogenic endothelium in disturbed flow regions -Targeted siRNA delivery to pro-atherogenic endothelium in vivo
por: Chung, Jihwa, et al.
Publicado: (2016)

SUN-560 Simvastatin Inhibits the Pro-Inflammatory and Pro-Atherogenic Effects of Cream in Obese Subjects
por: Goyal, Itivrita, et al.
Publicado: (2020)

Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells
por: Mohan, Girish C., et al.
Publicado: (2017)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

The pro-atherogenic response to disturbed blood flow is increased by a western diet, but not by old age
por: Walker, Ashley E., et al.
Publicado: (2019)

Arsenic Exposure Increases Monocyte Adhesion to the Vascular Endothelium, a Pro-Atherogenic Mechanism
por: Lemaire, Maryse, et al.
Publicado: (2015)

Patients with Concurrent Tuberculosis and Diabetes Have a Pro-Atherogenic Plasma Lipid Profile
por: Vrieling, Frank, et al.
Publicado: (2018)

Lignocellulosic Biomass as Sorbent for Fluoride Removal in Drinking Water
por: Robledo-Peralta, Adriana, et al.
Publicado: (2022)

Annexin A6 Polymorphism Is Associated with Pro-atherogenic Lipid Profiles and with the Downregulation of Methotrexate on Anti-Atherogenic Lipid Profiles in Psoriasis
por: Zhang, Fuxin, et al.
Publicado: (2022)

NF-κB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program
por: Kempe, Sybille, et al.
Publicado: (2005)

Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles
por: Syed, Shahan, et al.
Publicado: (2021)

Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells
por: Oksaharju, Anna, et al.
Publicado: (2009)

Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells
por: Pek, Nicole Min Qian, et al.
Publicado: (2019)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

In Vitro Interactions of Extracellular Histones with LDL Suggest a Potential Pro-Atherogenic Role
por: Pemberton, Alan D., et al.
Publicado: (2010)

Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment
por: Evani, Shankar J., et al.
Publicado: (2016)

Anorexia Nervosa Is Associated with a Shift to Pro-Atherogenic Low-Density Lipoprotein Subclasses
por: Stadler, Julia T., et al.
Publicado: (2022)

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
por: Huijser, Erika, et al.
Publicado: (2022)

Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
por: Cantin, Claudette, et al.
Publicado: (2022)

Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice
por: Liao, Birong, et al.
Publicado: (2008)

Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-α Treatment
por: Yeh, Kuo-Wei, et al.
Publicado: (2014)

Pro-atherogenic mediators and subclinical atherogenesis are related to epicardial adipose tissue thickness in patients with cardiovascular risk
por: Peraza-Zaldívar, Juan A, et al.
Publicado: (2016)

Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy
por: Reiss, Allison B., et al.
Publicado: (2019)

Uremic Conditions Drive Human Monocytes to Pro-Atherogenic Differentiation via an Angiotensin-Dependent Mechanism
por: Trojanowicz, Bogusz, et al.
Publicado: (2014)

NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype
por: Karlsen, Tom Rune, et al.
Publicado: (2021)

Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression
por: de Bruin, Ruben G., et al.
Publicado: (2016)

In-Vitro Sorbent-Mediated Removal of Edoxaban from Human Plasma and Albumin Solution
por: Angheloiu, Alexandra A., et al.
Publicado: (2020)

Pro-Resolving Ligands Orchestrate Phagocytosis
por: Decker, Christa, et al.
Publicado: (2021)

Disturbed Cyclical Stretch of Endothelial Cells Promotes Nuclear Expression of the Pro-Atherogenic Transcription Factor NF-κB
por: Pedrigi, Ryan M., et al.
Publicado: (2016)

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice
por: Schuster, Susanne, et al.
Publicado: (2019)

ApolipoproteinA1-75 G/A (M1(-)) polymorphism and Lipoprotein(a); Anti- vs. Pro-Atherogenic properties
por: Albahrani, Ali I, et al.
Publicado: (2007)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

The pro-atherogenic effects of macrophages are reduced upon formation of a complex between C-reactive protein and lysophosphatidylcholine
por: Chang, Mi-Kyung, et al.
Publicado: (2012)

B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis
por: Yang, Wenjing, et al.
Publicado: (2022)

Hybrid Pectin-Based Sorbents for Cesium Ion Removal
por: Bok-Badura, Joanna, et al.
Publicado: (2020)

A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice
por: Platko, Khrystyna, et al.
Publicado: (2023)

The bacteriolytic activity of native and covalently immobilized lysozyme against Gram‐positive and Gram‐negative bacteria is differentially affected by charged amino acids and glycine
por: Levashov, Pavel A., et al.
Publicado: (2019)

CD28(null) pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death
por: Pera, Alejandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e4jk08552b6h95c5h5232liqpl